Bali Bintang Sejahtera Tbk vs Merck Tbk. — how do they compare? Bali Bintang Sejahtera Tbk trades at Rp162 (market cap 972B, 333.7K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is the larger of the two by market cap, and Bali Bintang Sejahtera Tbk is more actively traded (333.7K versus 37.6K). Which is the better fit depends on your goals.
| BOLA | MERK | |
|---|---|---|
Market Cap | 972B | 1.7T |
Volume | 333.7K | 37.6K |
Lot | 3.34K | 376 |
Turnover | 53.73M | 144.47M |
Average Price | 161.02 | 3,842.23 |
Value | 53.73M | 144.47M |
Indicative Equilibrium Price | 162 | 3,840 |
Indicative Equilibrium Volume | 7.5K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bali Bintang Sejahtera (“the Company”) was established based on notarial deed No. 3 dated 3 December 2014 by Yurisa Martanti, S.H., M.H., notary in Jakarta. By the end of 2014, the Company acquired the business of Football Club Putra Samarinda (Pusam). In 2015, the Company has moved its home base club to Stadion Kapten I Wayan Dipta, Gianyar, Bali,Indonesia and registered its club in the Indonesia Football League with the name of Bali United Pusam. Furthermore in 2016, the Company has changed the registration of the name with the name of Bali United. Currently, the Company is taking care of the registration of a trademark rights and professional football club manager and Official Store "Bali United".
Read more on BOLA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →